HealthCor Management, L.P. Buys HCA Healthcare Inc, Thermo Fisher Scientific Inc, Quest Diagnostics Inc, Sells Dentsply Sirona Inc, Mednax Inc, Agilent Technologies Inc

• New Purchases: HCA, TMO, DGX, ALXN, DXCM, MDGL, UHS, CERN, CNC, EXAS,
• Added Positions: ANTM, MDT, VRTX, MRK, XENT, CELG, DVAX, PCRX, MASI, NBIX,
• Reduced Positions: UNH, ISRG, ZBH, AGN, LIVN, LH, BAX, QGEN, BMY, DHR,
• Sold Out: XRAY, MD, A, ABBV, IQV, GILD, ABC, HAE, EVHC, ACAD,

For the details of HealthCor Management, L.P.'s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=HealthCor+Management%2C+L.P.

1. Merck & Co Inc (MRK) - 4,184,160 shares, 8.06% of the total portfolio. Shares added by 14.39%
2. Regeneron Pharmaceuticals Inc (REGN) - 625,000 shares, 6.85% of the total portfolio.
3. Zimmer Biomet Holdings Inc (ZBH) - 1,925,000 shares, 6.81% of the total portfolio. Shares reduced by 17.2%
4. Laboratory Corp of America Holdings (LH) - 900,000 shares, 5.13% of the total portfolio. Shares reduced by 14.29%
5. Anthem Inc (ANTM) - 675,000 shares, 5.1% of the total portfolio. Shares added by 151.14%

HealthCor Management, L.P. initiated holding in HCA Healthcare Inc. The purchase prices were between $95.32 and $107.79, with an estimated average price of $101.14. The stock is now traded at around $130.01. The impact to a portfolio due to this purchase was 3.91%. The holding were 1,200,000 shares as of 2018-06-30.

HealthCor Management, L.P. initiated holding in Thermo Fisher Scientific Inc. The purchase prices were between $203.14 and $219.53, with an estimated average price of $212.33. The stock is now traded at around $231.61. The impact to a portfolio due to this purchase was 3.62%. The holding were 550,000 shares as of 2018-06-30.

HealthCor Management, L.P. initiated holding in Quest Diagnostics Inc. The purchase prices were between $97.35 and $113.14, with an estimated average price of $104.14. The stock is now traded at around $108.65. The impact to a portfolio due to this purchase was 3.48%. The holding were 997,580 shares as of 2018-06-30.

HealthCor Management, L.P. initiated holding in Alexion Pharmaceuticals Inc. The purchase prices were between $106.04 and $127.57, with an estimated average price of $116.88. The stock is now traded at around $119.68. The impact to a portfolio due to this purchase was 1.92%. The holding were 486,300 shares as of 2018-06-30.

HealthCor Management, L.P. initiated holding in DexCom Inc. The purchase prices were between $70.15 and $100.89, with an estimated average price of $84.75. The stock is now traded at around $127.43. The impact to a portfolio due to this purchase was 1.85%. The holding were 614,630 shares as of 2018-06-30.

HealthCor Management, L.P. initiated holding in Madrigal Pharmaceuticals Inc. The purchase prices were between $101.55 and $313.9, with an estimated average price of $174.17. The stock is now traded at around $236.88. The impact to a portfolio due to this purchase was 1.75%. The holding were 197,281 shares as of 2018-06-30.

HealthCor Management, L.P. added to a holding in Anthem Inc by 151.14%. The purchase prices were between $220.13 and $245.16, with an estimated average price of $231.73. The stock is now traded at around $264.97. The impact to a portfolio due to this purchase was 3.07%. The holding were 675,000 shares as of 2018-06-30.

HealthCor Management, L.P. added to a holding in Medtronic PLC by 527.33%. The purchase prices were between $77.48 and $87.83, with an estimated average price of $83.48. The stock is now traded at around $91.05. The impact to a portfolio due to this purchase was 1.71%. The holding were 747,270 shares as of 2018-06-30.

HealthCor Management, L.P. added to a holding in Vertex Pharmaceuticals Inc by 130.69%. The purchase prices were between $145.72 and $169.96, with an estimated average price of $155.03. The stock is now traded at around $175.93. The impact to a portfolio due to this purchase was 1.05%. The holding were 345,550 shares as of 2018-06-30.

HealthCor Management, L.P. added to a holding in Intersect ENT Inc by 172.96%. The purchase prices were between $36.2 and $42.7, with an estimated average price of $39.2. The stock is now traded at around $27.05. The impact to a portfolio due to this purchase was 0.96%. The holding were 1,268,850 shares as of 2018-06-30.

HealthCor Management, L.P. added to a holding in Celgene Corp by 39.89%. The purchase prices were between $74.69 and $92.08, with an estimated average price of $83.1. The stock is now traded at around $92.71. The impact to a portfolio due to this purchase was 0.68%. The holding were 952,670 shares as of 2018-06-30.

HealthCor Management, L.P. added to a holding in Dynavax Technologies Corp by 91.95%. The purchase prices were between $15.15 and $20.75, with an estimated average price of $17.31. The stock is now traded at around $13.30. The impact to a portfolio due to this purchase was 0.59%. The holding were 2,531,107 shares as of 2018-06-30.

HealthCor Management, L.P. sold out a holding in Dentsply Sirona Inc. The sale prices were between $42.29 and $50.64, with an estimated average price of $47.02.

HealthCor Management, L.P. sold out a holding in Mednax Inc. The sale prices were between $42.99 and $55.83, with an estimated average price of $47.95.

HealthCor Management, L.P. sold out a holding in Agilent Technologies Inc. The sale prices were between $61.14 and $69.55, with an estimated average price of $65.3.

HealthCor Management, L.P. sold out a holding in AbbVie Inc. The sale prices were between $89.78 and $106.23, with an estimated average price of $97.64.

HealthCor Management, L.P. sold out a holding in IQVIA Holdings Inc. The sale prices were between $94.85 and $105.95, with an estimated average price of $99.93.

HealthCor Management, L.P. sold out a holding in Gilead Sciences Inc. The sale prices were between $64.88 and $75.68, with an estimated average price of $70.67.